Living Well with Stroke: Design and Methods for a Randomized Controlled Trial of a Psychosocial Behavioral Intervention for Poststroke Depression

Journal of Stroke and Cerebrovascular Diseases

Volumn 17, Issue 3, 2008, Pages 109-115

  Mitchell, Pamela H ^a   Teri, Linda ^a   Veith, Richard ^a   Buzaitis, Ann ^a   Tirschwell, David ^a   Becker, Kyra ^a   Fruin, Michael ^a   Kohen, Ruth ^a   Cain, Kevin C ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

efficacy trial; Poststroke depression; psychosocial treatment

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BEHAVIOR THERAPY; CAREGIVER; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; FEMALE; HAMILTON SCALE; HUMAN; MALE; MEDICAL RESEARCH; METHODOLOGY; PRIORITY JOURNAL; PROBLEM SOLVING; PSYCHOLOGICAL RATING SCALE; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; SKILL; STROKE PATIENT; SURVIVOR; TREATMENT OUTCOME; WELLBEING;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; BEHAVIOR THERAPY; COMBINED MODALITY THERAPY; DATA INTERPRETATION, STATISTICAL; DEPRESSION; DISABILITY EVALUATION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NORTHWESTERN UNITED STATES; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; RECOVERY OF FUNCTION; RESEARCH DESIGN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 43049167173     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2007.12.002     Document Type: Article

References (43)

1. Hackett M.L., Yapa C., Parag V., et al. Frequency of depression after stroke: A systematic review of observational studies. Stroke 36 (2005) 1330-1340
2. van de Weg F.B., Kuik D.J., and Lankhorst G.J. Post-stroke depression and functional outcome: A cohort study investigating the influence of depression on functional recovery from stroke. Clin Rehabil 13 (1999) 268-272
3. Herrman N., Black S.E., Lawrence J., et al. The Sunnybrook stroke study: A prospective study of depressive symptoms and functional outcome. Stroke 29 (1998) 618-624
4. Shimoda K., and Robinson R.G. The relationship between social impairment and recovery from stroke. Psychiatry 61 (1998) 101-111
5. Ramasubbu R., Robinson R.G., Flint A.J., et al. Functional impairment associated with acute poststroke depression: The stroke data bank study. J Neuropsychiatry Clin Neurosci 10 (1998) 26-33
6. Morris P.L.P., Raphael B., and Robinson R.S. Clinical depression is associated with impaired recovery from sroke. Med J Aust 157 (1992) 239-242
7. Ormel J., Kempen G.I., Deeg D.J., et al. Functioning, well-being, and health perception in late middle-aged and older people: Comparing the effects of depressive symptoms and chronic medical conditions. J Am Geriatr Soc 46 (1998) 39-48
8. Clark M.S., and Smith D.S. The effects of depression and abnormal illness behavior on outcome following rehabilitation from stroke. Clin Rehabil 12 (1998) 73-80
9. Neau J.P., Ingrand P., Mouille-Brachet C., et al. Functional recovery and social outcome after cerebral infarction in young adults. Cerebrovasc Dis 8 (1998) 296-302
10. Parikh R.M., Robinson R.G., Lipsey J.R., et al. The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up. Arch Neurol 47 (1990) 785-789
11. Everson S.A., Roberts R.E., Goldberg D.E., et al. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med 158 (1998) 1133-1138
12. Morris P.L., Robinson R.G., Andrzejewski P., et al. Association of depression with 10-year poststroke mortality. Am J Psychiatry 150 (1993) 124-129
13. Hackett M.L., Anderson C.S., and House A.O. Interventions for treating depression after stroke. Cochrane Database Syst Rev 3 (2004) CD003437
14. Fruehwald S., Gatterbauer E., Rehak P., et al. Early fluoxetine treatment of post-stroke depression-a three-month double-blind placebo-controlled study with an open-label long-term follow up. J Neurol 250 (2003) 347-351
15. Williams L.S., Kroenke K., Bakas T., et al. Care management of poststroke depression: A randomized, controlled trial. Stroke 38 (2007) 998-1003
16. Watkins C.L., Auton M.F., Deans C.F., et al. Motivational interviewing early after acute stroke: A randomized, controlled trial. Stroke 38 (2007) 1004-1009
17. Arias B., Catalan R., Gasto C., et al. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. J Clin Psychopharmacol 23 (2003) 563-567
18. Durham L.K., Webb S.M., Milos P.M., et al. The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder. Psychopharmacology (Berl) 174 (2004) 525-529
19. Teri L. Behavioral treatment of depression in patients with dementia. Alzheimer Dis Assoc Disord 8 suppl (1994) 66-74
20. Logsdon R.G., and Teri L. Depression in Alzheimer's disease patients: Caregivers as surrogate reporters. J Am Geriatr Soc 43 (1995) 150-155
21. Teri L., Logsdon R.G., and McCurry S.M. The Seattle protocols: Advances in behavioral treatment of Alzheimer's disease. In: Grundman M., Feldman H., Fitten L.J., et al. (Eds). Research and practice in Alzheimer's disease (2005), Serdi Publisher, Paris 153-158
22. Yesavage J.A., Brink T.L., Rose T.L., et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 17 (1982) 37-49
23. Freedland K.E., Skala J.A., Carney R.M., et al. The Depression Interview and Structured Hamilton (DISH): Rationale, development, characteristics, and clinical validity. Psychosom Med 64 (2002) 897-905
24. Teri L., and Logsdon R.G. Methodologic issues regarding outcome measures for clinical drug trials of psychiatric complications in dementia. J Geriatr Psychiatry Neurol 8 suppl (1995) S8-S17
25. Teri L., Logsdon R.G., Uomoto J., et al. Behavioral treatment of depression in dementia patients: A controlled clinical trial. J Gerontol B Psychol Sci Soc Sci 52 (1997) 159-166
26. Teri L., Logsdon R.G., and McCurry S.M. Nonpharmacologic treatment of behavioral disturbance in dementia. Med Clin North Am 86 (2002) 641-656 viii
27. Logsdon R.G., and Teri L. The Pleasant Events Schedule-AD: Psychometric properties and relationship to depression and cognition in Alzheimer's disease patients. Gerontologist 37 (1997) 40-45
28. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
29. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6 (1967) 278-296
30. Duncan P.W., Wallace D., Lai S.M., et al. The stroke impact scale version 2.0: Evaluation of reliability, validity and sensitivity to change. Stroke 30 (1999) 2131-2140
31. Collin C., Wade D.T., Davies S., et al. The Barthel ADL Index: A reliability study. Int Disabil Stud 10 (1988) 61-63
32. Mahoney F.I., and Barthel D.W. Functional evaluation: The Barthel index. Md State Med J 14 (1965) 61-65
33. Scholte O.P., Reimer W.J., de Haan R.J., et al. Assessment of burden in partners of stroke patients with the sense of competence questionnaire. Stroke 29 (1998) 373-379
34. Mynors-Wallis L.M., Gath D.H., Lloyd-Thomas A.R., et al. Randomized controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. BMJ 310 (1995) 441-445
35. Mynors-Wallis L. Problem-solving treatment: Evidence for effectiveness and feasibility in primary care. Int J Psychiatry Med 26 (1996) 249-262
36. Mynors-Wallis L., Davies I., Gray A., et al. A randomized controlled trial and cost analysis of problem-solving treatment for emotional disorders given by community nurses in primary care. Br J Psychiatry 170 (1997) 113-119
37. Catalan J., Gath D.H., Anastasiades P., et al. Evaluation of a brief psychological treatment for emotional disorders in primary care. Psychol Med 21 (1991) 1013-1018
38. Keller M.B., McCullough J.P., Klein D.N., et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 342 (2000) 1462-1470
39. Murphy G.E., Simons A.D., Wetzel R.D., et al. Cognitive therapy and pharmacotherapy: Singly and together in the treatment of depression. Arch Gen Psychiatry 41 (1984) 33-41
40. Murphy G.E., Carney R.M., Knesevich M.A., et al. Cognitive behavior therapy, relaxation training, and tricyclic antidepressant medication in the treatment of depression. Psychol Rep 77 (1995) 403-420
41. Reynolds III C.F., Frank E., Perel J.M., et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: A randomized controlled trial in patients older than 59 years. JAMA 281 (1999) 39-45
42. Banerjee S., Shamash K., Macdonald A.J., et al. Randomized controlled trial of effect of intervention by psychogeriatric team on depression in frail elderly people at home. BMJ 313 (1996) 1058-1061
43. Mossey J.M., Knott K.A., Higgins M., et al. Effectiveness of a psychosocial intervention, interpersonal counseling, for subdysthymic depression in medically ill elderly. J Gerontol A Biol Sci Med Sci 51 (1996) M172-M178